Artificial intelligence could help improve diversity, equity, and inclusion in clinical trials and drug development by overcoming some traditional human bias in these areas, but we’re not there yet, experts say. The technology could also assist doctors with data insights to make diagnosis and treatment more precise.
Can AI Drive More Diversity in Drug Development?
Previous
Previous
AI ‘Simulants’ Could Save Time and Money on New Medications
Next
Next